Both CRC cell lines belong to the CMS1 (consensus molecular subtype 1), characterized by hypermutation, high microsatellite instability and pronounced immunogenicity (37), but differ in several tumorigenic markers such as APC, K-ras, B-raf, TGFBR2 and MLH1 (38). The gene discussed is MLH1; the disease is colorectal carcinoma.